CA2532067C — N-methyle-substituted benzamidazoles
Assigned to Warner Lambert Co LLC · Expires 2010-12-21 · 15y expired
What this patent protects
The present invention relates to N-methyl-substituted benzamidazole derivatives of formula (I), as defined in the specification; pharmaceutical compositions and mehtod of use thereof,as inhibitors of MEK.
USPTO Abstract
The present invention relates to N-methyl-substituted benzamidazole derivatives of formula (I), as defined in the specification; pharmaceutical compositions and mehtod of use thereof,as inhibitors of MEK.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.